Frontiers in Medicine, 2026
Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis

Tang L., Zhong L., Liang L. et al.

Journal of Proteome Research, 2026
Plasma Proteomic Signatures of Accelerometer-Measured Sedentary Behavior Are Associated with Future Disease Risk

Dai S., Chen Y., Huang S. et al.

The Journal of Clinical Endocrinology & Metabolism, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease

Gobeil ?., Bourgault J., Gagnon E. et al.

JCC Plus, 2026
Altered Levels of Enteric Glial Cells and Their Associated Pro‐Inflammatory Proteins in Patients With Ulcerative Colitis During Active Disease Compared to Remission and Healthy Controls

Beaudeau J., Katinios G., Lindqvist C. et al.

BMC Artificial Intelligence, 2026
Multimodal radiogenomic integration enhances prognostic and predictive modeling of liver and pancreas disorders

Koohi-Moghadam M., Vardhanabhuti V., Wang J. et al.

Nature Communications, 2026
AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease

Luo Y., Zhang N., Yang J. et al.

Cancer Science, 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

Mouri A., Kagamu H., Tamada K. et al.

Investigative Ophthalmology & Visual Science, 2026
Large-Scaled Proteomics Analysis for Glaucoma: Integrated Genetics, Multi-Omics, UK Biobank and Therapeutic Analysis

Xu J., Gao Y., Yu J. et al.

Cardiovascular Diabetology, 2026
Clinical subgroup-stratified plasma proteomic signatures improve risk prediction for myocardial infarction: SCORE2-Pro

Tong M., Zhang M., Xu M. et al.

Research, 2026
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

Research, 2026
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

ACR Open Rheumatology, 2026
Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort

McCuaig S., Toland C., Konvinse K. et al.

Mediators of Inflammation, 2026
Convergent Multistage Evidence Implicates the CCR2–Artemin Immune–Inflammation Axis in Acute Myeloid Leukemia

Jin Y., Lu H., Yu X. et al.

Mediators of Inflammation, 2026
Identification of Treatment Targets in Allergic Conjunctivitis Through Proteome‐Scale Mendelian Randomization Analysis

Li H., Zhang Y., Shang Y. et al.

BMC Medicine, 2026
CardioMetAge estimates cardiometabolic aging and predicts disease outcomes

Li Y., Xu X., Zheng Y. et al.

Journal of Neurosurgery: Pediatrics, 2026
Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations

Hattar Y., Sesen J., Martinez T. et al.

iScience, 2026
Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

C. dos Santos J., Groenendijk A., Ruijten S. et al.

International Journal of Biological Macromolecules, 2026
A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort

Wang H., Li X., Xu X. et al.

Journal of Translational Medicine, 2026
Machine learning-based clinical prediction model and multi-omics integration for assessing pancreatic cancer risk in new-onset diabetes

Yang J., Cao B., Yuemaierabola A. et al.

Journal for ImmunoTherapy of Cancer, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

O’Reilly E., Cabanski C., Lyman J. et al.